Literature DB >> 29276288

Hazardous Drug Contamination of Drug Preparation Devices and Staff: A Contamination Study Simulating the Use of Chemotherapy Drugs in a Clinical Setting.

Evan Call1, Brian Bill1, Chad McLean1, Nathan Call1, Allyn Bernkopf1, Craig Oberg1.   

Abstract

Background: Hazardous drug contamination (HD) in healthcare environments continues, placing healthcare staff at risk of significantly chronic health problems, despite the use of personal protective equipment (PPE) and closed system transfer device systems (CSTDs). Objective: This study's aim was to determine how HD might spread through touch after handling contaminated vials in simulated pharmacy and nursing environments.
Methods: UV fluorescent powder Glo Germ (Glo Germ Co., Moab, UT), composed of melamine resin, was used to simulate HD. Following manufacturer's exact usage specifications, five commercially available CSTDs were tested in the simulated pharmaceutical preparation environment under controlled conditions. UV fluorescence was used to detect the test medium powder that simulated HD following each trial. Photographs, using a Nikon D40X (10.2 mp) camera, were taken at selected stages of testing to document the presence of HD.
Results: Transfer of the HD testing medium (Glo Germ) to IV sets, pharmacy PPE, and nursing PPE was observed in 4 of 5 CSTDs tested. The only CSTDs that showed no observable contamination was the Allison Medical Safety Enclosed Vial Adapter (SEVA) system (Littleton, CO). Conclusions: Results show residue from HD vials spread as vial was handled in a pharmacy environment in 4 of 5 CSTDs, contaminating pharmacy PPE, ancillary products, and nursing PPE. No HD residue was detected on PPE, ancillary products, or nursing PPE in the pharmacy after using the SEVA system, providing an effective means to contain HD for drug transfer from vial to delivery system.

Entities:  

Keywords:  antineoplastic drugs; cleaning; health care; pilot study; surface contamination

Year:  2017        PMID: 29276288      PMCID: PMC5735723          DOI: 10.1177/0018578717722870

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  10 in total

1.  Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: results of three studies.

Authors:  Thomas H Connor; Paul J M Sessink; Bruce R Harrison; Jack R Pretty; Byron G Peters; Raul M Alfaro; Appie Bilos; Gwendolyn Beckmann; Michael R Bing; Lakisha M Anderson; Robert Dechristoforo
Journal:  Am J Health Syst Pharm       Date:  2005-03-01       Impact factor: 2.637

2.  Examining factors that influence the effectiveness of cleaning antineoplastic drugs from drug preparation surfaces: a pilot study.

Authors:  Chun-Yip Hon; Prescillia Ps Chua; Quinn Danyluk; George Astrakianakis
Journal:  J Oncol Pharm Pract       Date:  2013-08-08       Impact factor: 1.809

3.  Acute leukemia after treatment of lymphoma.

Authors:  J D Rowley; H M Golomb; J Vardiman
Journal:  N Engl J Med       Date:  1977-11-03       Impact factor: 91.245

4.  Pilot assessment of the antineoplastic drug contamination levels in British Columbian hospitals pre- and post-cleaning.

Authors:  Winnie C Chu; Chun-Yip Hon; Quinn Danyluk; Prescillia P S Chua; George Astrakianakis
Journal:  J Oncol Pharm Pract       Date:  2011-07-07       Impact factor: 1.809

5.  Use of a closed system drug-transfer device eliminates surface contamination with antineoplastic agents.

Authors:  Bernadette A Clark; Paul J M Sessink
Journal:  J Oncol Pharm Pract       Date:  2013-01-04       Impact factor: 1.809

6.  Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies - the MEWIP project.

Authors:  Thekla K Kiffmeyer; Jochen Tuerk; Moritz Hahn; Hartmut Stuetzer; Claudia Hadtstein; André Heinemann; Udo Eickmann
Journal:  Ann Occup Hyg       Date:  2012-11-02

7.  Determination of the external contamination and cross-contamination by cytotoxic drugs on the surfaces of vials available on the Swiss market.

Authors:  Sandrine Fleury-Souverain; Susanne Nussbaumer; Marc Mattiuzzo; Pascal Bonnabry
Journal:  J Oncol Pharm Pract       Date:  2013-05-14       Impact factor: 1.809

8.  Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs.

Authors:  Melissa A McDiarmid; Marc S Oliver; Tracy S Roth; Bonnie Rogers; Carmen Escalante
Journal:  J Occup Environ Med       Date:  2010-10       Impact factor: 2.162

9.  Multicentre study for the evaluation of mutagenic/carcinogenic risk in nurses exposed to antineoplastic drugs: assessment of DNA damage.

Authors:  Annamaria Buschini; Milena Villarini; Donatella Feretti; Francesca Mussi; Luca Dominici; Ilaria Zerbini; Massimo Moretti; Elisabetta Ceretti; Roberta Bonfiglioli; Mariella Carrieri; Umberto Gelatti; Carlo Rossi; Silvano Monarca; Paola Poli
Journal:  Occup Environ Med       Date:  2013-08-16       Impact factor: 4.402

10.  Occupational exposure to antineoplastic agents induces a high level of chromosome damage. Lack of an effect of GST polymorphisms.

Authors:  Antonella Testa; Manuela Giachelia; Selena Palma; Massimo Appolloni; Luca Padua; Giovanna Tranfo; Mariangela Spagnoli; Donatella Tirindelli; Renata Cozzi
Journal:  Toxicol Appl Pharmacol       Date:  2007-05-24       Impact factor: 4.219

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.